Can Enhancing Phagocytosis Help in Cancer Therapy?
Yes, enhancing phagocytosis is a promising strategy in cancer therapy. Therapeutic approaches that block "don't eat me" signals, such as anti-CD47 antibodies, can enhance the ability of immune cells to recognize and engulf cancer cells. This can potentially lead to better outcomes in cancer treatment.
